Pharmacological interest of Heligmosomoides polygyrus
Nottéghem, M.J.; Léger, N.; Forget, E.
Annales Pharmaceutiques Francaises 39(6): 537-543
1982
ISSN/ISBN: 0003-4509 PMID: 7092079 Document Number: 194461
Document emailed within 1 workday
Related Documents
Abu-Madi, M.A. 1997: The role of lipid content in the infectivity of third-stage larvae of Heligmosomoides polygyrus Journal of the Egyptian Society of Parasitology 27(3): 871-880Al-Bassel, D.A.; Stietieh, F.M.; Farrag, A.M. 2000: On the morphology of Heligmosomoides polygyrus (Nematoda-Trichostrongylidae) from the field mouse apodemus sylvaticus Journal of the Egyptian Society of Parasitology 30(1): 43-49
Boulenger, J.P.; Zarifian, E. 1981: Neuroleptic-tricyclic antidepressant combination. Pharmacological aspects and therapeutic interest L'Encephale 7(1): 5-28
Vandel, B.; Vandel, S.; Magnin, P. 1970: Pharmacological interest of the study of cellular metabolic changes of the central nervous system during convulsions. I. Study of the technical conditions in rats Therapie 25(1): 173-180
Devienne, M.-F.J. 2003: Interest of telemetric monitoring of energy consumption: application to human physiology, interest in pathology Annales de Biologie Clinique 61(2): 199-201
Liao, J.F.; Chen, C.F.; Chow, S.Y. 1981: Pharmacological studies of Chinese herbs. (9) Pharmacological effects of Evodiae fructus Journal of the Formosan Medical Association 80(1): 30-38
Chow, S.Y.; Chen, C.F.; Chen, S.M. 1977: Pharmacological studies of Chinese herbs. (6) Pharmacological effects of Epiphyllum oxypetalum Haw Journal of the Formosan Medical Association 76(12): 916-925
Schwartz, M.D.; Linzer, M.; Babbott, D.; Divine, G.W.; Broadhead, E. 1991: Medical student interest in internal medicine. Initial report of the Society of General Internal Medicine Interest Group Survey on Factors Influencing Career Choice in Internal Medicine Annals of Internal Medicine 114(1): 6-15
Johnson, G.F.; Wilson, P. 1989: The management of depression: a review of pharmacological and non-pharmacological treatments Medical Journal of Australia 151(7): 397-400 403 406
Hojo, M.; Nagasaka, Y.; Katayama, O.; Serizawa, I. 1981: Pharmacological study of Mequitazine (LM-209). (V). Pharmacological actions of a main metabolite of LM-209, mequitazine sulfoxide (LM-209 SO) Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(5): 431-438
Haulică, I.; Bild, W.; Boişteanu, D. 2006: Biosynthesis and physio-pharmacological actions of angiotensin peptides: 2. Physio-pharmacological properties Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(2): 384-390
Konno, F.; Kobayashi, C.; Morimoto, R.; Takayanagi, I.; Cho, N.; Hirobe, M. 1986: Pharmacological effects of nalorphine and nalorphine-7,8-oxide (nalorphine-epoxide): interaction of the intrinsic activity, affinity and pharmacological responses Archives Internationales de Pharmacodynamie et de Therapie 282(2): 219-232
Dilov, P.; Antonov, S.; Chakŭrov, R.; Petkov, R.; Gabrovski, P. 1984: Dextrofer-100 with B12 and dextrofer-100--comparative pharmacological and clinico-pharmacological studies Veterinarno-Meditsinski Nauki 21(6): 91-100
Flint, C. 1985: In whose interest? Nursing Times 81(15): 23
Teuscher, G.W. 1998: How deep our interest Asdc Journal of Dentistry for Children 65(3): 160
Amaral, M.A. 1992: Conflicts of interest Science 258(5089): 1717
Kohn, A. 1991: Conflict of interest Harefuah 121(7-8): 267-269
Smith, R. 1994: Conflict of interest and the BMJ Bmj 308(6920): 4-5
Connelly, M.E.; Goldstein, R.; Chandler, J.D.; Simonsen, R.J. 2007: A conflict of interest? Dentistry Today 26(9): 16
Stahl, B.D. 2002: Is this in the best interest of our patients? Dentistry Today 21(1): 10; 12